In this issue of Danish Pharmacovigilance Update:
News from the EU
- Cases of acquired haemophilia following treatment with clopidogrel (Plavix® etc.)
- Change in indication and contraindication for panitumumab (Vectibix®)
- Review of medicines containing zolpidem
- European Medicines Agency recommends suspension of medicines containing ketoconazole for oral use
- New recommendations for the use of painkillers containing diclofenac
- Until further notice, plasma substitutes containing hydroxyethyl starch (HES) for volume replacement in case of blood or plasma loss should be avoided in critically ill patients – including patients with sepsis
- Restrictions on the use of codeine for pain relief in children
- Risk of developing peripheral neuropathy during use of the fluoroquinolones class of antibiotics
News from the Danish Health and Medicines Authority
- Report of urinary retention in association with the use of atomoxetine
- The Danish Health and Medicines Authority's report on NSAIDs – a study of the number of users, reported suspected adverse reactions and inadvertent incidents
Short news
- Strong interest in Drug Analysis Prints with data from Danish adverse reaction reports
- The Danish Health and Medicines Authority: Information about cervical cancer and HPV vaccination